Yoshino Y - Search Results

1

Nicaraven enhances the cytotoxicity of X-ray irradiation in cancer cells with homologous recombination deficiency.

Yoshino Y, Ichimiya K, Jingu K, Fujita Y, Chiba N. Yoshino Y, et al. Biochem Biophys Res Commun. 2025 Jan;742:151153. doi: 10.1016/j.bbrc.2024.151153. Epub 2024 Dec 5. Biochem Biophys Res Commun. 2025. PMID: 39672008 Free article.

2

Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency.

Yoshino Y, Endo S, Chen Z, Qi H, Watanabe G, Chiba N. Yoshino Y, et al. Sci Rep. 2019 Feb 7;9(1):1644. doi: 10.1038/s41598-018-38311-x. Sci Rep. 2019. PMID: 30733539 Free PMC article.

3

Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway.

Yanaihara N, Yoshino Y, Noguchi D, Tabata J, Takenaka M, Iida Y, Saito M, Yanagida S, Iwamoto M, Kiyokawa T, Chiba N, Okamoto A. Yanaihara N, et al. Among authors: yoshino y. Gynecol Oncol. 2023 Jan;168:83-91. doi: 10.1016/j.ygyno.2022.11.006. Epub 2022 Nov 17. Gynecol Oncol. 2023. PMID: 36403366 Free article.

4

BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin.

Endo S, Yoshino Y, Shirota M, Watanabe G, Chiba N. Endo S, et al. Among authors: yoshino y. Cancer Res Commun. 2021 Nov 12;1(2):90-105. doi: 10.1158/2767-9764.CRC-21-0064. eCollection 2021 Nov. Cancer Res Commun. 2021. PMID: 36860287 Free PMC article.

5

Bevacizumab increases the sensitivity of olaparib to homologous recombination-proficient ovarian cancer by suppressing CRY1 via PI3K/AKT pathway.

Iida Y, Yanaihara N, Yoshino Y, Saito M, Saito R, Tabata J, Kawabata A, Takenaka M, Chiba N, Okamoto A. Iida Y, et al. Among authors: yoshino y. Front Oncol. 2024 Feb 14;14:1302850. doi: 10.3389/fonc.2024.1302850. eCollection 2024. Front Oncol. 2024. PMID: 38420012 Free PMC article.

6

Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity.

Motonari T, Yoshino Y, Haruta M, Endo S, Sasaki S, Miyashita M, Tada H, Watanabe G, Kaneko T, Ishida T, Chiba N. Motonari T, et al. Among authors: yoshino y. Sci Rep. 2024 Apr 8;14(1):7519. doi: 10.1038/s41598-024-57367-6. Sci Rep. 2024. PMID: 38589490 Free PMC article.

7

Dysregulation of the centrosome induced by BRCA1 deficiency contributes to tissue-specific carcinogenesis.

Yoshino Y, Fang Z, Qi H, Kobayashi A, Chiba N. Yoshino Y, et al. Cancer Sci. 2021 May;112(5):1679-1687. doi: 10.1111/cas.14859. Epub 2021 Mar 16. Cancer Sci. 2021. PMID: 33606355 Free PMC article. Review.

8

Roles of RACK1 in centrosome regulation and carcinogenesis.

Yoshino Y, Chiba N. Yoshino Y, et al. Cell Signal. 2022 Feb;90:110207. doi: 10.1016/j.cellsig.2021.110207. Epub 2021 Nov 27. Cell Signal. 2022. PMID: 34843916 Review.

9

Protocol to detect OLA1 polyubiquitination by Aurora A in vivo and in vitro.

Fang Z, Li X, Yoshino Y, Chiba N. Fang Z, et al. Among authors: yoshino y. STAR Protoc. 2024 Jun 21;5(2):103008. doi: 10.1016/j.xpro.2024.103008. Epub 2024 Apr 10. STAR Protoc. 2024. PMID: 38602870 Free PMC article.

10

The centrosome: a critical hub for cell cycle regulation.

Yoshino Y, Fang Z, Chiba N. Yoshino Y, et al. Trends Cell Biol. 2024 Jun;34(6):437-439. doi: 10.1016/j.tcb.2024.04.003. Epub 2024 Apr 25. Trends Cell Biol. 2024. PMID: 38670849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters